These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10802780)

  • 21. In vivo measurement of vesicular monoamine transporter type 2 density in Parkinson disease with (18)F-AV-133.
    Okamura N; Villemagne VL; Drago J; Pejoska S; Dhamija RK; Mulligan RS; Ellis JR; Ackermann U; O'Keefe G; Jones G; Kung HF; Pontecorvo MJ; Skovronsky D; Rowe CC
    J Nucl Med; 2010 Feb; 51(2):223-8. PubMed ID: 20080893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters.
    Kung MP; Hou C; Goswami R; Ponde DE; Kilbourn MR; Kung HF
    Nucl Med Biol; 2007 Apr; 34(3):239-46. PubMed ID: 17383573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo measurement of the vesicular monoamine transporter in schizophrenia.
    Taylor SF; Koeppe RA; Tandon R; Zubieta JK; Frey KA
    Neuropsychopharmacology; 2000 Dec; 23(6):667-75. PubMed ID: 11063922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.
    Koeppe RA; Frey KA; Vander Borght TM; Karlamangla A; Jewett DM; Lee LC; Kilbourn MR; Kuhl DE
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1288-99. PubMed ID: 8898703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain imaging of vesicular monoamine transporter type 2 in healthy aging subjects by 18F-FP-(+)-DTBZ PET.
    Lin KJ; Weng YH; Hsieh CJ; Lin WY; Wey SP; Kung MP; Yen TC; Lu CS; Hsiao IT
    PLoS One; 2013; 8(9):e75952. PubMed ID: 24098749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease.
    Gilman S; Koeppe RA; Little R; An H; Junck L; Giordani B; Persad C; Heumann M; Wernette K
    Ann Neurol; 2004 Jun; 55(6):774-80. PubMed ID: 15174011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obstructive sleep apnea is related to a thalamic cholinergic deficit in MSA.
    Gilman S; Chervin RD; Koeppe RA; Consens FB; Little R; An H; Junck L; Heumann M
    Neurology; 2003 Jul; 61(1):35-9. PubMed ID: 12847153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunochemical analysis of vesicular monoamine transporter (VMAT2) protein in Parkinson's disease.
    Miller GW; Erickson JD; Perez JT; Penland SN; Mash DC; Rye DB; Levey AI
    Exp Neurol; 1999 Mar; 156(1):138-48. PubMed ID: 10192785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Progression of dopaminergic hypofunction in striatal subregions in Parkinson's disease using [18F]CFT PET.
    Nurmi E; Bergman J; Eskola O; Solin O; Vahlberg T; Sonninen P; Rinne JO
    Synapse; 2003 Jun; 48(3):109-15. PubMed ID: 12645035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cholinergic vesicular transporters in progressive supranuclear palsy.
    Suzuki M; Desmond TJ; Albin RL; Frey KA
    Neurology; 2002 Apr; 58(7):1013-8. PubMed ID: 11940684
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome.
    Albin RL; Koeppe RA; Wernette K; Zhuang W; Nichols T; Kilbourn MR; Frey KA
    Neurology; 2009 Apr; 72(16):1390-6. PubMed ID: 19380698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study.
    Iranzo A; Valldeoriola F; Lomeña F; Molinuevo JL; Serradell M; Salamero M; Cot A; Ros D; Pavía J; Santamaria J; Tolosa E
    Lancet Neurol; 2011 Sep; 10(9):797-805. PubMed ID: 21802993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific.
    Kilbourn M; Lee L; Vander Borght T; Jewett D; Frey K
    Eur J Pharmacol; 1995 May; 278(3):249-52. PubMed ID: 7589162
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates.
    Zubieta JK; Huguelet P; Ohl LE; Koeppe RA; Kilbourn MR; Carr JM; Giordani BJ; Frey KA
    Am J Psychiatry; 2000 Oct; 157(10):1619-28. PubMed ID: 11007716
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of striatal vesicular monoamine transporter protein (VMAT2) in human cocaine users.
    Little KY; Krolewski DM; Zhang L; Cassin BJ
    Am J Psychiatry; 2003 Jan; 160(1):47-55. PubMed ID: 12505801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of rat brain vesicular monoamine transporter by chronic treatment with ovarian hormones.
    Rehavi M; Goldin M; Roz N; Weizman A
    Brain Res Mol Brain Res; 1998 Jun; 57(1):31-7. PubMed ID: 9630494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Caudate nucleus: influence of dopaminergic input on sequence learning and brain activation in Parkinsonism.
    Carbon M; Ma Y; Barnes A; Dhawan V; Chaly T; Ghilardi MF; Eidelberg D
    Neuroimage; 2004 Apr; 21(4):1497-507. PubMed ID: 15050574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term reproducibility of in vivo measures of specific binding of radioligands in rat brain.
    Kilbourn MR
    Nucl Med Biol; 2004 Jul; 31(5):591-5. PubMed ID: 15219277
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.
    Hogan KA; Staal RG; Sonsalla PK
    J Neurochem; 2000 May; 74(5):2217-20. PubMed ID: 10800969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Imaging the vesicular monoamine transporter.
    Frey KA; Koeppe RA; Kilbourn MR
    Adv Neurol; 2001; 86():237-47. PubMed ID: 11553983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.